Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'Trastuzumab'
Trastuzumab published presentations and documents on DocSlides.
Eribulin Mesylate + Trastuzumab
by easyho
as First-Line Therapy for Locally Recurrent or . M...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
Fast relapsing
by danika-pritchard
patients . i.e. Patient relapses during or within...
William J.
by tawny-fly
Gradishar. . MD, FACP. Betsy . Bramsen. Profess...
Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer
by faustina-dinatale
Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
Module 9: HER2-Positive and
by norah
Triple-Negative Breast Cancer. Jamie Carroll, APRN...
Part B Medical Drugs Requiring Step
by udeline
-TherapyDrug subject to Step TherapyTry these Opti...
Part B Medical Drugs Requiring StepTherapy
by natalie
Drug subject to Step Therapy BRAND NAME GENERIC NA...
Budget impact and cost-effectiveness of oncology
by roxanne
biosimilars. Prof. dr. Steven Simoens. Health econ...
Cost Impact Of Biosimiliars in Oncology
by williams
Mansoor A Khan, BS, MS, BCOP. Senior Clinical Phar...
Breast Cancer in Older Patients
by ButterflyKisses
Key Issues. Etienne GC . Brain. , MD . PhD. Instit...
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
by gelbero
Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...
Risk of Heart Failure in Breast Cancer Patients After
by sophia2
Anthracycline. and . Trastuzumab. Treatment: A R...
Her2 + Breast Cancer Laura
by ximena
Bidstrup. Mrs B is a 49 . yo. woman who attended ...
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín
by delcy
Trastuzumab-emtansine. : A . very. . nice. . poi...
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
MUGA scans
by danika-pritchard
&. monitoring of chemotherapy. Cardiovascular...
New Therapies for Metastatic Breast Cancer
by alexa-scheidler
Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...
Breast Cancer Highlights From San Antonio
by tatyana-admore
Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...
update in metastatic breast c
by min-jolicoeur
. Dr.Mina. . Tajvidi. Radiation . oncologist. ...
ID DB06366 CATEGORY
by luanne-stotts
Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...
Systemic Therapy for Breast Cancer
by natalia-silvester
Adjuvant or Neoadjuvant. Agustin A Garcia, MD, MM...
Updates in the Treatment of Breast cancer
by alexa-scheidler
Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...
Dawid Sigorski, Ph.D .
by morgan
Department. of . oncology. . UWM. Epidemiology. ...
DRUG NAMES AND MEDICATION ERRORS
by freya
1. DRUG NAMES. Chemical name. Development name use...
HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ
by carny
Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...
CoclusteringofErbB1andErbB2RevealedbyFRETSensitizedAcceptorBleachingg
by cora
SubmittedDecember10,2009,andacceptedforpublication...
Antibody–Drug Conjugates in Development for Non-
by elizabeth
s. mall Cell . Lung Cancer. , Gastric Cancer, and ...
Antibody–Drug Conjugates
by wang
in Development for . Breast Cancer. Sara A. Hurvit...
Advanced Breast Cancer 31 year old female px severe pain right UL ‘burning’ pain
by margaret
Background of lower back pain for 3/12 . No past ...
GIULIANA D’AURIA UOC Oncologia ASL Roma 2
by hadley
Osp. . Pertini-S.Eugenio-CTO. Therapeutic. . app...
Metastatic triple-positive
by marcos147
breast. . cancer. . needs. . different. . ther...
Load More...